The Rhythm Evaluation for AntiCoagulaTion with Continuous Monitoring of Atrial Fibrillation (REACT-AF) clinical trial compares the current standard of care for AF versus a novel…
COVID-19, the disease caused by the SARS-CoV-2 virus, began spreading in late 2019. Global health authorities quickly started tracking and studying the outbreak. By March 11, 2020, the World…
“I’m going to tell the story of the development of the Division of Brain Injury Outcomes into an academic research organization,” began BIOS director Daniel…
Attendees of the European Stroke Organisation Conference this month had a chance to learn about the OPTIMISTmain trial from its principal investigator, Victor Urrutia, MD.…
Daniel Hanley, MD, BIOS division director, and Issam Awad, MD, director of neurovascular surgery at UChicago Medicine, joined the November 2019 episode of the Neurocritical…
A neurosurgical clinical trial that did not meet its primary endpoint offers valuable clues nonetheless, argue the authors of a commentary published in The Journal…